FibroBiologicsFBLG

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative discdisease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1

$359.9M

Market Cap • 20/05/2024

2021

(há 3 anos)
Fundação

2024

IPO

NASDAQ

Listagem
Flag of US

Houston

Sede • Texas

Valuation

Valuation Indicators

Retorno Histórico

FBLGSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

-3%

1 dia

17/05/2024

7%

1 semana

13/05/2024

2%

1 mês

22/04/2024

10 anos

Histórico